clf065
clf065: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: GH Research PLC (GHRS)
Development Pipeline (1)
| Company | Phase |
|---|---|
| GH Research PLC (GHRS) | Phase 2 |
Clinical Trials (1)
A Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CLF065 in the Treatment of Chronic Pouchitis
Frequently asked questions
Who is developing clf065?
clf065 is being developed by GH Research PLC.
How many clinical trials involve clf065?
BioSniper tracks 1 clinical trial involving clf065.
Analyze GH Research PLC & clf065 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company